Table 1.
Sex | MRI | Neurological and/or developmental problems | NRAS genotype | BRAF genotype | MC1R genotype | Multiple CMN | Postnatal/ recurrent nodules | Classic facies |
---|---|---|---|---|---|---|---|---|
Male 53 (39·6) |
Normal 67 (71·3) |
Yes 23 (18·3) |
Mutation positive 80 (68·4) p.(Q61K) 59 (73·8) p.(Q61R) 17 (21·3) p.(Q61H) 3 (3·8) p.(G13R) 1 (1·25) |
BRAF p.(V600E) 7 (7·3) |
At least one MC1R variant 47 (62·7) |
Multiple 94 (75·8) |
Present 26 (22·4) |
Present 66 (68·8) |
Female 81 (60·4) |
Abnormal 27 (28·7) |
None 103 (81·7) |
Mutation negative 37 (31·6) | Mutation negative 89 (92·7) |
No MC1R variants 28 (37·3) |
Single 30 (24·2) |
Absent 89 (76·7) |
Absent 30 (31·3) |
Missing n = 0 |
Missing n = 40 |
Missing n = 8 |
Missing n = 17 |
Missing n = 38 |
Missing n = 59 |
Missing n = 10 |
Missing n = 19 |
Missing n = 38 |
All data are presented as n (%) unless otherwise stated. MRI, magnetic resonance imaging; CMN, congenital melanocytic naevi.